CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-24 | Dere Willard H Director | Grant or award | +4,980 | 23,390 | ||
| 2022-05-24 | ANDERSON ELIZABETH M Director | Grant or award | +4,980 | 18,890 | ||
| 2022-05-24 | Alles Mark J Director | Grant or award | +4,980 | 7,280 | ||
| 2022-05-16 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award | +11,130 | 11,130 | ||
| 2022-05-16 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award · Stock Option (Right to buy Common Stock) | +17,490 | 17,490 | ||
| 2022-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +20,000 | $37.46 | $749K | 355,324 |
| 2022-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −20,000 | $81.00 | $1.6M | 335,324 |
| 2022-05-06 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −20,000 | 0 | ||
| 2022-05-05 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +10,000 | $37.46 | $375K | 345,324 |
| 2022-05-05 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −10,000 | $84.14 | $841K | 335,324 |
| 2022-05-05 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −10,000 | 20,000 | ||
| 2022-05-04 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −3,926 | $84.65 | $332K | 48,373 |
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +2,038 | $37.46 | $76K | 40,677 |
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Sale | −2,038 | $84.50 | $172K | 38,639 |
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +9,762 | $37.46 | $366K | 48,401 |
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Sale | −9,762 | $84.50 | $825K | 38,639 |
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −2,038 | 0 | ||
| 2022-05-04 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −9,762 | 0 | ||
| 2022-05-02 | MEIER RICHARD A Director | Exercise or conversion | +8,500 | $37.46 | $318K | 107,892 |
| 2022-05-02 | MEIER RICHARD A Director | Sale | −3,860 | $82.09 | $317K | 104,032 |
Page 22 of 23 · 450 trades